These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28385895)

  • 1. Deep vein thrombosis in a transgender woman.
    Chan W; Drummond A; Kelly M
    CMAJ; 2017 Apr; 189(13):E502-E504. PubMed ID: 28385895
    [No Abstract]   [Full Text] [Related]  

  • 2. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic hemodynamics in postmenopausal women following cessation of hormone therapy.
    Harvey RE; Johnson MC; Ranadive SM; Joyner MJ; Lahr BD; Miller VM; Barnes JN
    Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29208690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
    Kaunitz AM
    Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of Rivaroxaban for Mesenteric Vein Thrombosis Secondary to Diverticulitis: A Case Report.
    Parthvi R; Mehra S
    Am J Ther; 2017; 24(5):e629-e630. PubMed ID: 27759584
    [No Abstract]   [Full Text] [Related]  

  • 11. Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital.
    Clapham RE; Speed V; Czuprynska J; Gazes A; Guppy S; Patel RK; Rea C; Vadher B; Arya R; Roberts LN
    Br J Haematol; 2022 Jan; 196(1):e3-e6. PubMed ID: 34355385
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and benefit considerations for menopausal hormone therapy.
    Pickar JH; Archer DF; Kagan R; Pinkerton JV; Taylor HS
    Expert Opin Drug Saf; 2017 Aug; 16(8):941-954. PubMed ID: 28664754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent deep vein thrombosis with rivaroxaban in a patient with metastatic testicular cancer.
    Eid TJ; Kalkat B; Shah SA
    J Pharm Pract; 2015 Jun; 28(3):233. PubMed ID: 25979903
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
    Ta V; Chin WK; White AA
    Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
    [No Abstract]   [Full Text] [Related]  

  • 15. A current perspective into young female sex hormone replacement: a review.
    Giordano Imbroll M; Gruppetta M
    Expert Rev Endocrinol Metab; 2020 Nov; 15(6):405-414. PubMed ID: 32893689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban for the treatment of cerebral venous thrombosis.
    Mutgi SA; Grose NA; Behrouz R
    Int J Stroke; 2015 Oct; 10 Suppl A100():167-8. PubMed ID: 26502976
    [No Abstract]   [Full Text] [Related]  

  • 17. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
    Canonico M; Scarabin PY
    Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.